Unsere Kongressbeiträge
Kongressbeiträge 2022
Lâm TT, Wohlfarth E, Claus H, Vogel C, Kresken M. Antibiotic resistance in Haemophilus influenzae isolates obtained from patients at outpatient departments in Germany, 2019/2020. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Oral Session OF094, Abstract 537, Talk O0394
Wagenlehner F, Kresken M, Naber K, Cheng WY, Catillon M, Mulgirigama A, Duh MS, Yu L, Khanal A, Joshi AV, Ju S, Mitrani-Gold FS. Treatment patterns and outcomes among females with uncomplicated urinary tract infection in Germany: a physician-based chart review. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS012, Abstract 657, Poster P0346
Naber K, Kresken M, Wagenlehner F, Cheng WY, Catillon M, Mulgirigama A, Duh MS, Yu L, Khanal A, Joshi AV, Ju S, Mitrani-Gold FS. Antimicrobial resistance patterns and patient characteristics among females with uncomplicated urinary tract infection in Germany: a physician-based chart review. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS018, Abstract 655, Poster P0595
Kresken M, Gatermann SG, Higgins PG, Pfeifer Y, Pfennigwerth N, Seifert H, Werner G, Wohlfarth E. Comparative in-vitro activity of cefiderocol and four newer β-lactam/β-lactamase inhibitor combinations against two panels of clinically important Gramnegative pathogens from Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS018, Abstract 629, Poster P0599
Kresken M, Wohlfarth E, Pfeifer Y, Werner G. Multidrug-resistance to oral antibiotics among Escherichia coli urine isolates from patients at outpatient departments in Germany and in vitro activity of nitroxoline, Germany, 2010-2019. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS018, Abstract 584, Poster P0684
Kresken M, Pfeifer Y, Wagenlehner F, Werner G, Wohlfarth E. Resistance to mecillinam and nine other antibiotics for oral use in Escherichia coli isolated from urine specimens of primary care patients in Germany, 2019/2020. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS018, Abstract 526, Poster P0685
Kresken M, Wohlfarth E, Weikel C, Butler D, Pfeifer Y, Werner G. In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS018, Abstract 60, Poster P0686
Neumann B, Rackwitz W, Pfennigwerth N, Hunfeld K-P, Kresken M, Leistner R, Probst-Kepper M, Hammerl JA, Werner G, Pfeifer Y. Highly conserved mcr-1-carrying plasmids but polyclonal spread of colistin-resistant Escherichia coli from human patients and livestock products in Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS020, Abstract 1494, Poster P0840
Hamprecht A, Kresken M, Mack D, Molitor E, Gatermann S. Detection of carbapenemases in Enterobacterales: presentation of the new German guideline. 32nd European Congress of Clinical Microbiology and Infectious Diseases, Lisbon / Online, 23-26 April 2022. Poster Session PS021, Abstract 2280, Poster P0864
Kongressbeiträge 2021
Kresken M, Körber-Irrgang B, Korte-Berwanger M, Pfennigwerth N, Gatermann SG, Wohlfarth E, Seifert H. In vitro activity of ceftolozane/tazobactam against Enterobacterales and Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia in Germany. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, ePoster, Abstract No. 395
Kresken M, Wohlfarth E, Wichelhaus TA, Gatermann SG, Seifert H. Multidrug resistance in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa and susceptibility to four last resort antimicrobials, Germany. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, ePoster, Abstract No. 443
Rackwitz W, Neumann B, Pfennigwerth N, Hunfeld KP, Kresken M, Leistner R, Probst-Kepper M, Fuchs S, Werner G, Pfeifer Y. Genome-based characterisation of colistin-resistant Escherichia coli isolates from human patients and livestock products in Germany. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, ePoster, Abstract No. 2164
Weber R, Fleige C, Layer F, Neumann B, Kresken M, Werner G. Determination of a dalbavancin epidemiological cut-off value (ECOFF) for Enterococcus faecium. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, ePoster, Abstract No. 4385
Kresken M, Klare I, Wichelhaus TA, Wohlfarth E, Werner G. In vitro activity of dalbavancin against glycopeptide-resistant Enterococcus faecium and coagulase-negative staphylococci recovered from patients in Germany. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, Oral Session, Abstract No. 393
Wohlfarth E, Kresken M, Higgins P, Stefanik D, Wille J, Körber-Irrgang B, Seifert H. The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019. 31st European Congress of Clinical Microbiology and Infectious Diseases, Online, 9-12 July 2021, Oral Session, Abstract No. 4821
Kongressbeiträge 2020
M. Groschel, C. Meehan, I. Barilar, M. Diricks, A. Gonzaga, M. Steglich, O. Conchillo-Sole, I. Scherer, U. Mamat, C. Luz, K. De Bruyne, C. Utpatel, D. Yero, I. Gibert, X. Daura, S. Kampmeier, N. Abdul Rahman, M. Kresken, T. Van Der Werf, I. Alio, W. Streit, K. Zhou, T. Schwartz, J. Rossen, U. Schaible, M. Farhat, U. NĂĽbel, J. Rupp, J. Steinmann, S. Niemann, T. Kohl. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. 30th European Congress of Clinical Microbiology and Infectious Diseases, 2020, Abstract Book: Abstract 48, p. 259.
Abstract
L. Blanchard, T. Armstrong, D. Gerald, Y. Ying, M. Kresken, J. Carpenter, V. Sauvonnet, G. Zambardi. Eravacycline for antimicrobial susceptibility testing of Enterobacteriaceae and Enterococcus spp.: performance results from a multi-centre study. 30th European Congress of Clinical Microbiology and Infectious Diseases, 2020, Abstract Book: Abstract 1079, p. 566.
Abstract
M. Kresken, M. Korte-Berwanger, N. Pfennigwerth, S. Gatermann. In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany: 2016-17. 30th European Congress of Clinical Microbiology and Infectious Diseases, 2020, Abstract Book: Abstract 1089, p. 568.
B. Neumann, M. Kresken, G. Werner. Genome-based surveillance of clinical vancomycin-resistant Enterococcus faecium reveals increased prevalence of vanB-type isolates of ST117/CT71 in German hospitals, 2010-2016. 30th European Congress of Clinical Microbiology and Infectious Diseases, 2020, Abstract Book: Abstract 1735, p. 839.